Extended Data Fig. 4: Antibody levels against infection agents and vaccinations.
From: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Antibody levels against measles, rubella, mumps, varicella zoster virus (VZV), hepatitis B (HBs, hepatitis B surface antigen), tetanus, diphtheria and pneumococci (PPV23, polyvalent pneumococcal vaccine -23) at baseline and 3 months after CAR T cell administration (N = 5).
